Coronavir
Coronavir is an anti-viral drug approved in Russia for the treatment of COVID-19. Little is known of this drug, except for the information released by its developer R-Pharm.[1][2]
By the description provided to the press, coronavir seems to be an inhibitor of SARS-CoV-2 RNA polymerase, similar to other antiviral nucleotide analogues such as remdesivir.[1] The drug appears to be based on favipiravir, a drug developed in Japan.[3]
Coronavir was approved for use in Russia in hospitals in July 2020, and in September 2020 it received approval for prescription sales for outpatient use.[3]
See also
References
- ^ a b "Russian firm gets approval for drug said to block coronavirus replication". July 8, 2020 – via in.reuters.com.
- ^ "Russia approves R-Pharm's Coronavir for Covid-19 treatment". Pharmaceutical Technology. 9 July 2020. Retrieved 21 July 2020.
- ^ a b Reuters Staff (2020-09-18). "Russia approves first COVID-19 prescription drug for sale in pharmacies". Reuters (in French). Retrieved 2020-09-20.
{{cite news}}:|author=has generic name (help)
 | This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |